金年会-(中国)金字招牌,信誉至上

    • 2002

      Sinocare was established

    • 2004

      Launched the first SXT-1 blood glucose meter, and developed test strips with automatic capillary action for sample collection

    • 2007

      Engaged in China-Cuba biotechnology cooperation and realized large-scale export to Cuba and Latin American markets

    • 2012

      Sinocare went public on SZSE (Shenzhen Stock Exchange), the first listed company of blood glucose meter in China

    • 2015

      Developed China’s first truly hospital-grade blood glucose meter: Gold-Accu

    • 2016

      Acquisition of largest US based BGM manufacturer Nipro Diagnostic Inc.(Now renamed as Trividia Health Inc.) and PTS Diagnostics Inc.

    • 2017

      Sinocare Hospital diabetes management system was implemented

    • 2019

      AGEscan, a non-invasive diabetes risk screening product, opening a new entrance to the whole course management of diabetes

    • 2020

      iPOCT standardization laboratory is marketed officially in CMEF Shanghai

    • 2022

      Sinocare Qingshan Park - the new iPOCT industrial park was put into use

    • 2023

      The Continuous Glucose Monitoring (CGMS) product-Sinocare iCan officially obtained the product registration certificate

    • 2002
    • 2004
    • 2007
    • 2012
    • 2015
    • 2016
    • 2017
    • 2019
    • 2020
    • 2022
    • 2023
    友情链接: